Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028754 (
obesity
)
124,988
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Genetic studies in humans provide a method to test hypotheses about the biological roles of specific genes. So far, ten published papers have chosen to examine the hypothesis that uncoupling protein-2 (UCP2) and/or
UCP3
influence energy expenditure and/or body fat accumulation. These genes were chosen because they are candidate energy expenditure genes, based on their homology to UCP1. Studies of UCP2 and
UCP3
are intrinsically intertwined because the two genes are separated by only 6000 base pairs on human chromosome 11. Linkage studies in families have suggested that UCP2 and/or
UCP3
, or a closely linked gene, may influence resting metabolic rate (RMR) Some association studies using a 3' untranslated region insertion/deletion variant of UCP2 have produced statistically positive evidence for association with body mass index (BMI) and RMR. In contrast, association studies of UCP2 using an Ala to Val variant at amino acid 55 have produced negative results. Positive results have also been reported for association of a
UCP3
splice variant with respiratory quotient in African Americans. In addition, no studies have reported linkage or association of UCP2 or
UCP3
with diabetes. Overall, the results suggest that some variants of UCP2 and
UCP3
may be associated with
obesity
traits in some populations. The UCPs, to date, show positive results in associations with
obesity
traits but not with diabetes traits. Further work will be needed to settle the role of UCP2 and
UCP3
alleles in human body weight regulation.
...
PMID:Genetics of uncoupling proteins in humans. 1045 22
Uncoupling protein-2 (UCP2) and
uncoupling protein-3
(
UCP3
) are mitochondrial proteins that may play a role in the control of energy expenditure by uncoupling respiration from ATP synthesis. The present review focuses on data obtained in humans. UCP2 is widely expressed in the body, whereas
UCP3
expression is restricted to skeletal muscle. Positive correlations have been reported between UCP2 mRNA concentrations in adipose tissue,
UCP3
mRNA concentrations in skeletal muscle, and components of the metabolic rate. Fasting induces an up-regulation of UCP2 and
UCP3
mRNA expression. In vivo and in vitro studies suggest that fatty acids could modulate uncoupling protein gene expression. The putative relationship between
obesity
, energy expenditure and uncoupling protein expression, and the unexpected rise in UCP2 and
UCP3
mRNA concentrations during short-term fasting, are discussed in view of the recent data obtained in rodents and cell lines.
...
PMID:Uncoupling protein-2 (UCP2) and uncoupling protein-3 (UCP3) expression in adipose tissue and skeletal muscle in humans. 1045 28
Uncoupling protein 1 (UCP1) dissipates energy and generates heat by catalyzing back-flux of protons into the mitochondrial matrix, probably by a fatty acid cycling mechanism. If the newly discovered UCP2 and
UCP3
function similarly, they will enhance peripheral energy expenditure and are potential molecular targets for the treatment of
obesity
. We expressed UCP2 and
UCP3
in Escherichia coli and reconstituted the detergent-extracted proteins into liposomes. Ion flux studies show that purified UCP2 and
UCP3
behave identically to UCP1. They catalyze electrophoretic flux of protons and alkylsulfonates, and proton flux exhibits an obligatory requirement for fatty acids. Proton flux is inhibited by purine nucleotides but with much lower affinity than observed with UCP1. These findings are consistent with the hypothesis that UCP2 and
UCP3
behave as uncoupling proteins in the cell.
...
PMID:Transport function and regulation of mitochondrial uncoupling proteins 2 and 3. 1047 45
By virtue of its potential effects on rates of energy expenditure,
uncoupling protein 3
(
UCP3
) is an
obesity
candidate gene. We identified nine sequence variants in
UCP3
, including Val9Met, Val102Ile, Arg282Cys, and a splice site mutation in the intron between exons 6 and 7. The splice mutation results in an inability to synthesize mRNA for the long isoform (UCP3L) of
UCP3
. Linkage (sib pair), association, and transmission disequilibrium testing studies on 942 African-Americans did not suggest a significant effect of
UCP3
on body composition in this group. In vastus lateralis skeletal muscle of individuals homozygous for the splice mutation, no UCP3L mRNA was detectable; the short isoform (UCP3S) was present in an increased amount. In this muscle, we detected no alterations of in vitro mitochondrial coupling activity, mitochondrial respiratory enzyme activity, or systemic oxygen consumption or respiratory quotient at rest or during exercise. These genetic and physiologic data suggest the following possibilities: UCP3S has uncoupling capabilities equivalent to UCP3L; other UCPs may compensate for a deficiency of bioactive UCP3L; UCP3L does not function primarily as a mitochondrial uncoupling protein.
...
PMID:Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasis. 1048 Jun 26
Human uncoupling protein (
UCP3
) is a mitochondrial transmembrane carrier that uncouples oxidative phosphorylation and is a candidate gene for
obesity
. Expression of native human
UCP3
mutations in yeast showed complete loss (R70W), significant reduction (R143X), or no effect (V102I and IVS6+1G > A) on the uncoupling activity of
UCP3
. It is concluded that certain mutations in
UCP3
alter its functional impact on membrane potential (deltaphi), possibly conferring susceptibility to develop metabolic diseases.
...
PMID:Endogenous mutations in human uncoupling protein 3 alter its functional properties. 1061 3
Human
uncoupling protein 3
(
UCP3
) has two RNA transcripts that arise from the differential processing of the same gene product. One encodes the full length protein (UCP3L) while the other encodes a truncated version (
UCP3S
) lacking the sixth membrane spanning domain. The roles of the two isoforms are not known, but a mutation that decreases the proportion of UCP3L decreases fat oxidation and increases susceptibility to
obesity
. In the ADP/ATP carrier, a protein closely related to
UCP3
, the sixth membrane spanning domain is required for insertion into the inner membrane. Therefore, defective membrane insertion of
UCP3S
may account for the different effects of the two isoforms in vivo. We investigated mitochondrial import of the two
UCP3
isoforms. When epitope-tagged versions of
UCP3S
and UCP3L were expressed in COS7 cells, both were inserted into the mitochondrial inner membrane. Translation in vitro followed by incubation with isolated mitochondria showed that both isoforms were inserted into the inner membrane, however, the insertion of
UCP3S
was significantly slower.
...
PMID:Mitochondrial import of the long and short isoforms of human uncoupling protein 3. 1063 20
The availability of a UCP1-ablated mouse has enabled critical studies of the function of UCP1, UCP2, and
UCP3
. Concerning UCP1, its presence in brown-fat mitochondria is associated with innate uncoupling, high GDP-binding capacity, and GDP-inhibitable Cl- permeability and uncoupling--but the high fatty acid sensitivity found in these mitochondria is observed even in the absence of UCP1. The absence of UCP1 leads to low cold tolerance but not to
obesity
. UCP1 ablation also leads to an augmented expression of UCP2 and
UCP3
in brown adipose tissue, making this tissue probably the one that boasts the highest expression of these UCPs. However, these very high expression levels are not associated with any inherent uncoupling, or with a specific GDP-binding capacity, or with a GDP-sensitive Cl- permeability, or with any effect of GDP on mitochondrial membrane potential, or with an increased basal metabolism of cells, or with the presence of norepinephrine- or fatty acid-induced thermogenesis in cells, and not with a cold-acclimation recruited, norepinephrine-induced thermogenic response in the intact animal. Therefore, it can be discussed whether any uncoupling effect is associated with UCP2 or
UCP3
when they are endogenously expressed and, consequently, whether (loss of) uncoupling (thermogenic) effects of UCP2 or
UCP3
can be invoked to explain metabolic phenomena, such as
obesity
.
...
PMID:UCP1: the original uncoupling protein--and perhaps the only one? New perspectives on UCP1, UCP2, and UCP3 in the light of the bioenergetics of the UCP1-ablated mice. 1065 76
The recently cloned uncoupling protein homolog
UCP3
is expressed primarily in muscle and therefore may play a significant role in the regulation of energy expenditure and body weight. However, investigation into the regulation of uncoupling protein has been hampered by the inability to assess its activity in vivo. In this report, we demonstrate the use of a noninvasive NMR technique to assess mitochondrial energy uncoupling in skeletal muscle of awake rats by combining (13)C NMR to measure rates of mitochondrial substrate oxidation with (31)P NMR to assess unidirectional ATP synthesis flux. These combined (31)P/(13)C NMR measurements were performed in control, 10-day triiodo-l-thyronine (T(3))-treated (model of increased
UCP3
expression), and acute 2,4-dinitrophenol (DNP)-treated (protonophore and mitochondrial uncoupler) rats.
UCP3
mRNA and protein levels increased 8.1-fold (+/- 1.1) and 2.8-fold (+/- 0.8), respectively, in the T(3)-treated vs. control rat gastrocnemius muscle. (13)C NMR measurements of tricarboxylic acid cycle flux as an index of mitochondrial substrate oxidation were 61 +/- 21, 148 +/- 25, and 310 +/- 48 nmol/g per min in the control, T(3), and DNP groups, respectively. (31)P NMR saturation transfer measurements of unidirectional ATP synthesis flux were 83 +/- 14, 84 +/- 14, and 73 +/- 7 nmol/g per s in the control, T(3), and DNP groups, respectively. Together, these flux measurements, when normalized to the control group, suggest that acute administration of DNP (mitochondrial uncoupler) and chronic administration of T(3) decrease energy coupling by approximately 80% and approximately 60%, respectively, and that the latter treatment correlates with an increase in
UCP3
mRNA and protein expression. This NMR approach could prove useful for exploring the regulation of uncoupling protein activity in vivo and elucidating its role in energy metabolism and
obesity
.
...
PMID:Assessment of mitochondrial energy coupling in vivo by 13C/31P NMR. 1082 16
This review addresses the hypothesis that polyunsaturated fatty acids (PUFA), particularly those of the n-3 family, play essential roles in the maintenance of energy balance and glucose metabolism. The data discussed indicate that dietary PUFA function as fuel partitioners in that they direct glucose toward glycogen storage, and direct fatty acids away from triglyceride synthesis and assimilation and toward fatty acid oxidation. In addition, the n-3 family of PUFA appear to have the unique ability to enhance thermogenesis and thereby reduce the efficiency of body fat deposition. PUFA exert their effects on lipid metabolism and thermogenesis by upregulating the transcription of the mitochondrial
uncoupling protein-3
, and inducing genes encoding proteins involved in fatty acid oxidation (e.g. carnitine palmitoyltransferase and acyl-CoA oxidase) while simultaneously down-regulating the transcription of genes encoding proteins involved in lipid synthesis (e.g. fatty acid synthase). The potential transcriptional mechanism and the transcription factors affected by PUFA are discussed. Moreover, the data are interpreted in the context of the role that PUFA may play as dietary factors in the development of
obesity
and insulin resistance. Collectively the results of these studies suggest that the metabolic functions governed by PUFA should be considered as part of the criteria utilized in defining the dietary needs for n-6 and n-3 PUFA, and in establishing the optimum dietary ratio for n-6:n-3 fatty acids.
...
PMID:Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. 1088 93
We investigated the relative importance of overeating, thermogenesis, and uncoupling protein (UCP) expression in determining the severity of
obesity
in male Wistar rats fed a highly palatable diet. After 2 wk of feeding, body weight did not differ significantly from controls (248 +/- 4 vs. 229 +/- 3 g; P > 0.3), but rectal temperature, brown adipose tissue (BAT) mass,
UCP3
expression in gastrocnemius muscle, and UCP2 expression in white adipose tissue (WAT) were all elevated in diet-fed animals. In a further study, rats fed a palatable diet for 8 wk exhibited higher energy intake and rectal temperature than controls. Dietary-obese rats were divided into high (427-490 g; n = 8) and low (313-410 g; n = 10) weight gainers. The high gainers ate significantly more than the low gainers, and energy intake was positively correlated with weight gain (r(2) = 0.72, P < 0.01). UCP2 and
UCP3
mRNA levels in gastrocnemius muscle were significantly increased above lean controls in all diet-fed animals, whereas UCPs in WAT and BAT did not differ significantly from controls. Whereas rats fed palatable food exhibited a thermogenic response, there was no significant difference in core temperature between high and low gain groups (37. 5 +/- 0.1 vs. 37.6 +/- 0.1 degrees C; P > 0.5). We conclude that a higher energy intake is the critical factor determining susceptibility to dietary
obesity
in unselected Wistar rats.
...
PMID:Individual severity of dietary obesity in unselected Wistar rats: relationship with hyperphagia. 1091 34
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>